|
Re: Zenith Abstract at AACR 2017 Meeting April 1-5
|
3
|
Zenith Epigenetics
|
Mar 31, 2017 04:57PM
|
|
Re: Extended Betonmace trial
|
3
|
Resverlogix Corp.
|
Apr 20, 2017 05:28PM
|
|
Re: Revamped RVX Homepage, New Content
|
3
|
Resverlogix Corp.
|
Jul 28, 2015 07:59PM
|
|
Re: Kidney data rocks!
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 12:53PM
|
|
Re: Managing Diabetes & CVD: Is epigenetics a new way forward?
|
3
|
Resverlogix Corp.
|
Jun 23, 2017 10:51AM
|
|
Zacks SCR Resverlogix R&D Update 10/17/16
|
3
|
Resverlogix Corp.
|
Oct 18, 2016 06:37AM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
3
|
Resverlogix Corp.
|
Dec 02, 2019 11:12AM
|
|
Re: Zenith Abstract at AACR 2017 Meeting April 1-5
|
3
|
Zenith Epigenetics
|
Mar 31, 2017 05:09PM
|
|
Re: AHA 2018 Resverlogix Poster #1
|
3
|
Resverlogix Corp.
|
Nov 12, 2018 10:46PM
|
|
Re: State of Emergency
|
3
|
Resverlogix Corp.
|
Jul 22, 2016 02:31PM
|
|
Re: Monday!
|
3
|
Resverlogix Corp.
|
Sep 27, 2019 10:38AM
|
|
Re: A few thoughts
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 12:56PM
|
|
Re: RRR %
|
3
|
Resverlogix Corp.
|
Jul 01, 2019 12:50PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
3
|
Zenith Epigenetics
|
Sep 17, 2017 09:28PM
|
|
Re: ASCO study...Celgene
|
3
|
Zenith Epigenetics
|
Jun 01, 2019 02:30PM
|
|
Re: Properly powered? What does the FDA think?
|
3
|
Resverlogix Corp.
|
May 11, 2018 11:04AM
|
|
Re: American Heart Association 2017
|
3
|
Resverlogix Corp.
|
Nov 13, 2017 05:24PM
|
|
Re: Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress
|
3
|
Resverlogix Corp.
|
May 26, 2018 11:17AM
|
|
Re: Resverlogix AGM webcast 9/12/2018
|
3
|
Resverlogix Corp.
|
Sep 11, 2018 03:38PM
|
|
Re: IR reply...
|
3
|
Resverlogix Corp.
|
Dec 19, 2018 07:42PM
|
